Evidence map›Paper›PMID 33642127›Full record

ArticleThe American journal of emergency medicine2021

Neuroleptic malignant syndrome following COVID-19 vaccination.

Mostafa Alfishawy, Zouheir Bitar, Amr Elgazzar, Mahmoud Elzoueiry

Abstract readLetterComment
In one paragraph

Article in The American journal of emergency medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Neuroleptic Malignant Syndrome Concurrent with COVID-19 Infection: A Case Report.Turk psikiyatri dergisi = Turkish journal of psychiatry · 2024
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Spectrum of neurological complications following COVID-19 vaccination.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Mostafa AlfishawyInfectious Diseases Consultants and Academic Researchers of Egypt (IDCARE), Egypt. Electronic address: malfishawy@kasralainy.edu.eg.
Zouheir BitarAhmadi Hospital of Kuwait Oil Company, Kuwait City, Kuwait.
Amr ElgazzarAhmadi Hospital of Kuwait Oil Company, Kuwait City, Kuwait.
Mahmoud ElzoueiryAhmadi Hospital of Kuwait Oil Company, Kuwait City, Kuwait.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Neuroleptic Malignant SyndromeCOVID-19 VaccinesHumansSARS-CoV-2VaccinationCOVID-19 Vaccines

Identifiers

PMID33642127
PMCPMC8555970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.